A new USPTO proposal could encourage counsel to advise their patent owner clients to file fewer terminal disclaimers, say sources. The USPTO released a notice of proposed rulemaking on May 9 that ...
“The USPTO should not be weaponized against the biopharmaceutical industry.” – Sherry Knowles The U.S. Patent and Trademark Office (USPTO) today officially withdrew its controversial proposed rule on ...
If adopted, the pending rule would reshape litigation strategy and offer patent defendants a valuable tool, say Kristen Lovin and Niall Frizzell of Keker, Van Nest & Peters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results